Nomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy

BACKGROUND: Colorectal cancer is a common digestive cancer worldwide. As a comprehensive treatment for locally advanced rectal cancer (LARC), neoadjuvant therapy (NT) has been increasingly used as the standard treatment for clinical stage II/III rectal cancer. However, few patients achieve a complet...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Fang-Ze, Mei, Shi-Wen, Chen, Jia-Nan, Wang, Zhi-Jie, Shen, Hai-Yu, Li, Juan, Zhao, Fu-Qiang, Liu, Zheng, Liu, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673964/
https://www.ncbi.nlm.nih.gov/pubmed/33268952
http://dx.doi.org/10.3748/wjg.v26.i42.6638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673964/
https://www.ncbi.nlm.nih.gov/pubmed/33268952
http://dx.doi.org/10.3748/wjg.v26.i42.6638

Ejemplares similares